High Response Rates and Durable Remissions in Patients with Previously Untreated Advanced-Stage Follicular Lymphoma Treated with Tositumomab and Iodine I-131 Tositumomab (Bexxar)

Reviewer: Walter Sall, MD
OncoLink
Ultima Vez Modificado: 7 de diciembre del 2002

Translation for this article does not exist